KERRY TAKEDA: Open Payments
NPI 1811681497 · LA VISTA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,483 in 82 payments from 25 companies in 2025. Trend: 2023 $511 · 2024 $1,743 · 2025 $1,483
Food & beverage: $1,483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $350 |
| Lilly USA, LLC | 7 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $113 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Novo Nordisk Inc | 3 | $60 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, UBRELVY, QULIPTA, Kerendia, MOUNJARO.
Industry payments across NE — which companies pay providers there.
